Modification to Coulter LH 750 Hematology Analyzer
510(k) K052905
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK052905 | Date18 Nov 2005 | StatusActive |
Recalls
-
- Terminated Z-3113-2017
Beckman Coulter has determined that additional clarification for the Blast Suspect messages is necessary. In rare situations, the LH 750, LH 780, LH 500 and HmX Analyzers may not flag or detect blasts in some blood samples.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GKZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5220
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Modification to Coulter LH 750 Hematology Analyzer is a quantitative, automated hematology analyzer and leukocyte differential counter for in vitro diagnostic use in clinical laboratories. It provides automated reticulocyte analysis and enumeration of nucleated red blood cells (NRBCs) as well as an automated method for enumeration of RBCs and WBCs in body fluids.
This device modification involves labeling update for quality control (QC) procedure regarding nucleated red blood cells (NRBCs). The device is authorized under FDA 510(k) K052905 and is classified as a Class II device with product code GKZ. It is manufactured by Beckman Coulter, Inc. and is intended for use in clinical laboratory settings.
Other devices from Beckman Coulter, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the Modification to Coulter LH 750 Hematology Analyzer used for?
This device is a quantitative, automated hematology analyzer and leukocyte differential counter for in vitro diagnostic use in clinical laboratories. It provides automated reticulocyte analysis, enumeration of nucleated red blood cells (NRBCs), and an automated method for enumeration of RBCs and WBCs in body fluids.
What does the modification to the Coulter LH 750 involve?
The modification involves a labeling update for quality control (QC) procedure regarding nucleated red blood cells (NRBCs). This update ensures proper guidance for laboratory personnel when using the device for NRBC analysis.
What is the regulatory status of this device?
The device is authorized under FDA 510(k) K052905 and is classified as a Class II device with product code GKZ. It is manufactured by Beckman Coulter, Inc. and is intended for use in clinical laboratory settings.
What are the key features of the Coulter LH 750 Hematology Analyzer?
The analyzer provides automated reticulocyte analysis and enumeration of nucleated red blood cells (NRBCs) as well as an automated method for enumeration of red blood cells and white blood cells in body fluids, making it a comprehensive tool for hematology analysis in clinical laboratories.